287 related articles for article (PubMed ID: 18439681)
1. The effect of topical bevacizumab on corneal neovascularization.
Kim SW; Ha BJ; Kim EK; Tchah H; Kim TI
Ophthalmology; 2008 Jun; 115(6):e33-8. PubMed ID: 18439681
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab for corneal neovascularization.
Jacobs DS; Lim M; Carrasquillo KG; Rosenthal P
Ophthalmology; 2009 Mar; 116(3):592-3; author reply 593-4. PubMed ID: 19264217
[No Abstract] [Full Text] [Related]
3. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
Oh JY; Kim MK; Wee WR
Cornea; 2009 Oct; 28(9):1070-3. PubMed ID: 19724199
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
You IC; Kang IS; Lee SH; Yoon KC
Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
[TBL] [Abstract][Full Text] [Related]
5. Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome.
Uy HS; Chan PS; Ang RE
Cornea; 2008 Jan; 27(1):70-3. PubMed ID: 18245970
[TBL] [Abstract][Full Text] [Related]
6. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
[TBL] [Abstract][Full Text] [Related]
7. High-dose topical bevacizumab for corneal neovascularization.
Waisbourd M; Levinger E; Varssano D; Moisseiev E; Zayit-Soudri S; Barak A; Loewenstein A; Barequet I
Pharmacology; 2013; 92(5-6):310-4. PubMed ID: 24335191
[TBL] [Abstract][Full Text] [Related]
8. Subconjunctival bevacizumab for corneal neovascularization.
Zaki AA; Farid SF
Acta Ophthalmol; 2010 Dec; 88(8):868-71. PubMed ID: 19519730
[TBL] [Abstract][Full Text] [Related]
9. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
[TBL] [Abstract][Full Text] [Related]
10. Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.
Chu HS; Hu FR; Yang CM; Yeh PT; Chen YM; Hou YC; Chen WL
Cornea; 2011 Jan; 30(1):60-6. PubMed ID: 20847676
[TBL] [Abstract][Full Text] [Related]
11. [Subconjunctival bevacizumab for corneal neovascularization].
Gueudry J; Richez F; Tougeron-Brousseau B; Genevois O; Muraine M
J Fr Ophtalmol; 2010 Nov; 33(9):630-6. PubMed ID: 21035899
[TBL] [Abstract][Full Text] [Related]
12. Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.
Dastjerdi MH; Al-Arfaj KM; Nallasamy N; Hamrah P; Jurkunas UV; Pineda R; Pavan-Langston D; Dana R
Arch Ophthalmol; 2009 Apr; 127(4):381-9. PubMed ID: 19365012
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization.
Habot-Wilner Z; Barequet IS; Ivanir Y; Moisseiev J; Rosner M
Acta Ophthalmol; 2010 Dec; 88(8):862-7. PubMed ID: 19549103
[TBL] [Abstract][Full Text] [Related]
14. Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study.
Benayoun Y; Adenis JP; Casse G; Forte R; Robert PY
Cornea; 2012 Aug; 31(8):937-44. PubMed ID: 22357391
[TBL] [Abstract][Full Text] [Related]
15. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization.
Koenig Y; Bock F; Horn F; Kruse F; Straub K; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1375-82. PubMed ID: 19415316
[TBL] [Abstract][Full Text] [Related]
17. Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization.
Qian CX; Bahar I; Levinger E; Rootman D
Cornea; 2008 Oct; 27(9):1090-2. PubMed ID: 18812781
[TBL] [Abstract][Full Text] [Related]
18. Perilimbal bevacizumab injection for interface neovascularization after deep anterior lamellar keratoplasty.
Foroutan A; Fariba B; Pejman B; Mahmoud J; Khalil GF; Arash EA; Foroutan P
Cornea; 2010 Nov; 29(11):1268-72. PubMed ID: 20802316
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival bevacizumab for corneal neovascularization.
Doctor PP; Bhat PV; Foster CS
Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization.
Asena L; Akova YA; Cetinkaya A; Kucukerdonmez C
Acta Ophthalmol; 2013 May; 91(3):e246-8. PubMed ID: 22998029
[No Abstract] [Full Text] [Related]
[Next] [New Search]